$1.36 Billion is the total value of Aequim Alternative Investments LP's 86 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 73.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SOLN | Sell | SOUTHERN CORPORATE SRS A UNTunit 08/01/2022 | $5,190,000 | -25.7% | 100,000 | -33.3% | 0.38% | -58.8% |
| NVTA | Sell | INVITAE CORP | $1,994,000 | -60.3% | 47,700 | -58.9% | 0.15% | -78.1% |
| Sell | BLACKSTONE MTG TR INCnote 4.375% 5/0 | $1,304,000 | -25.0% | 1,300,000 | -27.8% | 0.10% | -58.6% | |
| ON | Sell | ON SEMICONDUCTOR ORD | $1,263,000 | +26.0% | 38,600 | -16.5% | 0.09% | -30.1% |
| OI | Sell | O-I GLASS INC | $789,000 | -43.8% | 66,300 | -50.0% | 0.06% | -69.0% |
| BMYRT | Exit | BRISTOL-MYERS SQUIBB COright 99/99/9999 | $0 | – | -50,000 | -100.0% | -0.02% | – |
| CATM | Exit | CARDTRONICS PLC | $0 | – | -75,400 | -100.0% | -0.20% | – |
| Exit | APELLIS PHARMACEUTICALS INCnote 3.500% 9/1 | $0 | – | -1,500,000 | -100.0% | -0.22% | – | |
| ECPG | Exit | ENCORE CAP GROUP INC | $0 | – | -68,500 | -100.0% | -0.35% | – |
| UTZWS | Exit | UTZ BRANDS INC*w exp 08/28/202 | $0 | – | -506,403 | -100.0% | -0.44% | – |
| Exit | NEUROCRINE BIOSCIENCES INCnote 2.250% 5/1 | $0 | – | -3,000,000 | -100.0% | -0.55% | – | |
| ENRPRA | Exit | ENERGIZER HLDGS INC NEW7.5 mcnv pfd a | $0 | – | -50,000 | -100.0% | -0.55% | – |
| Exit | NUTANIX INCnote 1/1 | $0 | – | -5,000,000 | -100.0% | -0.63% | – | |
| BSXPRA | Exit | BOSTON SCIENTIFIC CORP5.50% cnv pfd a | $0 | – | -50,000 | -100.0% | -0.74% | – |
| Exit | PRA GROUP INCnote 3.500% 6/0 | $0 | – | -6,000,000 | -100.0% | -0.88% | – | |
| NIO | Exit | NIO INCspon ads | $0 | – | -369,900 | -100.0% | -1.04% | – |
| DHRPRA | Exit | DANAHER CORPORATION4.75 mnd cv pfd | $0 | – | -9,000 | -100.0% | -1.77% | – |
| QTSPRB | Exit | QTS RLTY TR INC6.50% con pfd b | $0 | – | -135,688 | -100.0% | -2.56% | – |
| Exit | WRIGHT MED GROUP N Vnote 2.250%11/1 | $0 | – | -28,000,000 | -100.0% | -5.36% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2021-02-16
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NICE SYS INC | 19 | Q3 2023 | 6.3% |
| BIOMARIN PHARMACEUTICAL INC | 18 | Q3 2023 | 0.8% |
| EURONET WORLDWIDE ORD | 18 | Q3 2023 | 0.4% |
| CLEVELAND CLIFFS ORD | 17 | Q3 2023 | 1.9% |
| AIR TRANSPORT SERVICES GRP I | 17 | Q1 2023 | 0.5% |
| LIBERTY MEDIA CORP DELAWARE | 16 | Q3 2023 | 5.6% |
| ECHOSTAR CORP | 16 | Q3 2023 | 0.9% |
| BAUSCH HEALTH COS INC | 15 | Q1 2023 | 0.3% |
| O-I GLASS INC | 15 | Q3 2023 | 0.2% |
| JAZZ PHARMACEUTICALS PLC | 14 | Q3 2023 | 0.1% |
View Aequim Alternative Investments LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-15 |
| 13F-HR | 2023-08-10 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-14 |
| SC 13G | 2023-01-10 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-10 |
View Aequim Alternative Investments LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.